COVID-19-Vaccination-Induced Localized Lichen Planus Successfully Treated With Phototherapy

Lichen planus (LP) is an inflammatory autoimmune mucocutaneous disease with different forms and presentations. It mainly affects the skin and oral mucosa but could also affect genital mucosa, nails, hair, and, rarely, the larynx and esophagus. Since the start of the COVID-19 era, multiple cutaneous...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2024-08, Vol.16 (8), p.e66907
Main Author: Al Dhafiri, Mahdi
Format: Article
Language:English
Subjects:
Allergy/Immunology
Alopecia
Baldness
Coronaviruses
COVID-19 vaccines
Cytokines
Dermatology
Edema
Erythema
Herpes viruses
Infections
Infectious Disease
Light therapy
mRNA vaccines
Pandemics
Pathogenesis
Polyethylene glycol
Proteins
Purpura
Steroids
Urticaria
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lichen planus (LP) is an inflammatory autoimmune mucocutaneous disease with different forms and presentations. It mainly affects the skin and oral mucosa but could also affect genital mucosa, nails, hair, and, rarely, the larynx and esophagus. Since the start of the COVID-19 era, multiple cutaneous manifestations related to SARS-CoV-2 infection or vaccination have been reported. Different rare cases of lichen planus were reported after COVID-19 infection and vaccination. This report elaborates on and adds an additional case of localized cutaneous lichen planus (CLP) to the upper extremities, which developed after both doses of the mRNA vaccine and improved after phototherapy.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.66907